Asymmetric benzazole derivatives as dual antibiofilm and anti-wall teichoic acid agents against Staphylococcus aureus
Future Medicinal Chemistry · 2026
DOI: 10.1080/17568919.2026.2714028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Future Medicinal Chemistry, 2026. Verfasst von Mine Buga Aktekin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Mersin University, Mersin, Türkiye. Hauptthemen laut MEDLINE: Biofilms, Teichoic Acids, Anti-Bacterial Agents, Staphylococcus aureus. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Mersin University.
Abstract (Originalsprache)
AIMS: Antibiotic-resistant bacteria, particularly methicillin-resistant Staphylococcus aureus (MRSA), have renewed interest in antivirulence strategies. This study aimed to design, synthesize, and evaluate asymmetric di‑heterocyclic benzazole derivatives as antibiofilm agents targeting wall teichoic acid (WTA) biosynthesis. MATERIALS AND METHODS: Twenty‑one novel bis‑heterocyclic benzazole derivatives bearing an ethyl‑thio linker were synthesized and characterized. Antibacterial activity was determined by broth microdilution. Antibiofilm activity (inhibition and eradication) was assessed at sub‑minimal inhibitory concentrations (sub‑MICs) using crystal violet. Molecular docking and 200 ns molecular dynamics (MD) simulations were performed against key WTA enzymes (TarGH, TarS, TarM, TarL, and TarJ). RESULTS: Compounds 18, 21, 23, and 24 showed potent antibacterial activity against methicillin‑susceptible S. aureus (MSSA) and MRSA, with MIC values as low as 15.62 µg/mL. All selected compounds significantly inhibited biofilm at sub‑MIC levels. Compound 24 was most effective, with an MBIC50 of 3.90 µg/mL against MSSA and eradicated pre‑formed biofilms at 7.81 µg/mL. Docking and MD simulations revealed stable interactions of compounds 23 and 24 with TarGH and TarS, suggesting a WTA‑targeting mechanism. CONCLUSIONS: Di‑heterocyclic benzazole derivatives, especially compound 24, are promising scaffolds for antibiofilm agents against S. aureus. Our findings support further mechanistic and preclinical evaluation as potential antivirulence therapeutics. Antibiotic-resistant bacteria, such as Staphylococcus aureus (often called “staph”), are a growing global health threat. Traditional antibiotics are becoming less effective, so scientists are looking for new ways to fight infections. One promising strategy is to target the bacteria’s ability to cause disease rather than trying to kill them directly. This study focuses on a new set of molecules designed to stop S. aureus from forming biofilms—slimy protective layers that make infections harder to treat.We created 21 new compounds and tested them against both regular and methicillin-susceptible S. aureus (MSSA) and antibiotic-resistant (methicillin-resistant S. aureus, MRSA) strains. The most effective ones significantly reduced biofilm formation. One compound, named compound 24, was particularly powerful, needing only a very low dose to work.Using computer models, we explored how these compounds might work. They appear to interact with key proteins that the bacteria need to build their cell walls, a process essential for biofilm formation. This suggests a possible mechanism for their anti-biofilm activity.These findings are important because they point toward a new class of potential drugs that could be used to combat stubborn S. aureus infections, offering an alternative to traditional antibiotics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Mersin University, Mersin, Türkiye.
- Department of Pharmacy Services, Vocational School of Health Services, Tarsus University, Mersin, Türkiye.
- Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Mersin University, Mersin, Türkiye.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, İnönü University, Malatya, Türkiye.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Erzincan Binali Yıldırım University Yalnizbag Campus, Erzincan, Türkiye.
ORCID-Profile: Mine Buga Aktekin, Zehra Oksuz, Mehmet Abdullah Alagoz, Bahar Uluca Han, Oztekin Algul
Förderung
- Mersin University
Zitieren
APA
Buga Aktekin, M., Oksuz, Z., Alagoz, M. A., Uluca Han, B., & Algul, O. (2026). Asymmetric benzazole derivatives as dual antibiofilm and anti-wall teichoic acid agents against Staphylococcus aureus. Future Medicinal Chemistry. https://doi.org/10.1080/17568919.2026.2714028
Vancouver
Buga Aktekin M, Oksuz Z, Alagoz MA, Uluca Han B, Algul O. Asymmetric benzazole derivatives as dual antibiofilm and anti-wall teichoic acid agents against Staphylococcus aureus. Future Medicinal Chemistry. 2026. doi:10.1080/17568919.2026.2714028
BibTeX
@article{BugaAktekin2026,
author = {Buga Aktekin, Mine and Oksuz, Zehra and Alagoz, Mehmet Abdullah and Uluca Han, Bahar and Algul, Oztekin},
title = {Asymmetric benzazole derivatives as dual antibiofilm and anti-wall teichoic acid agents against Staphylococcus aureus},
journal = {Future Medicinal Chemistry},
year = {2026},
doi = {10.1080/17568919.2026.2714028}
}
EUVIMED